« Back
Home /
Tabimorelin

Tabimorelin

Item no.	HY-121580-1mg
Manufacturer	MedChem Express
CASRN	193079-69-5
Amount	1 mg
Specific against	other
Citations	[1]Zdravkovic M, et al. A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate. Eur J Clin Pharmacol. 2003 Feb;58(10):683-8.
Smiles	CC(N)(C/C=C/C(N([C@H](CC1=CC=C2C=CC=CC2=C1)C(N([C@H](CC3=CC=CC=C3)C(NC)=O)C)=O)C)=O)C
Alias	NN703
Available
Product Description	Tabimorelin (NN703) is an orally active growth hormone (GH) secretagogue. Tabimorelin is also a potent inhibitor of CYP3A4 activity[1].
Shipping	Room temperature
Manufacturers Applications	Metabolism-sugar/lipid metabolism
MolecularWeight	528.69
Clinical Information	Phase 2
Manufacturers Research Area	Endocrinology
Solubility	10 mM in DMSO
Target	Cytochrome P450
Manufacturers Target	Cytochrome P450
Isoform	CYP3
Manufacturers Pathway	Metabolic Enzyme/Protease
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Request delivery time